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ABSTRACT: Phenylalanine-arginine β-naphthylamide
(PAβN) is a broad-spectrum eﬄux pump inhibitor that has
shown to potentiate the activity of antibiotics in Gram-
negative bacteria. AdeB is a part of the AdeABC tripartite
pump that plays a pivotal role in conferring eﬄux-mediated
resistance in Acinetobacter baumannii. To understand the
molecular mechanism of eﬄux pump inhibition by PAβN, we
investigated the interaction of PAβN with AdeB using diﬀerent
computational methods. We observed that PAβN does not
have speciﬁc binding interactions with the proximal binding
site and interacts strongly with the distal binding pocket. The
Phe loop located between the proximal and distal binding
pockets plays a key role in the PAβN-mediated inhibition and acts as a gate between the binding pockets. Molecular dynamics
simulations suggested that PAβN behaved like a climber as we observed switching of the interaction energies between the ligand
and the key Phe residues of the binding site during the course of the simulation. PAβN uses the hydrophobic microenvironment
formed by Phe residues in the distal binding pocket to keep the binding monomer in the binding conformation. The simulation
data suggests that this binding event should result in the inhibition of the peristaltic mechanism and prevent the exporter from
extruding any other substrates leading to the inhibition of the tripartite pump.
1. INTRODUCTION
Multidrug-resistant (MDR) bacteria have emerged as a major
concern for public health, and there are particular concerns
about the emergence of a number of Gram-negative pathogens,
for which there are dwindling treatment options and few
compounds are in development. These pathogens are
characterized by the ability to rapidly develop and acquire
resistance mechanisms in response to exposure to diﬀerent
antimicrobial agents. A key part of the armory of these
pathogens is a series of eﬄux pumps, which eﬀectively exclude
or reduce the intracellular concentration of a large number of
antibiotics and other compounds, making the pathogens
signiﬁcantly more resistant. These eﬄux pumps are a topic of
considerable interest, both from the perspective of under-
standing eﬄux pump function and also as targets for novel
adjunct therapies.
Resistance-nodulation-division (RND) multidrug eﬄux
pumps are tripartite systems, situated in the three-layer
(outer membrane, periplasmic space, and inner membrane)
envelope of Gram-negative bacteria,1 consisting of an outer
membrane protein (OMP) or channel such as AdeC, TolC, or
OprM; a fusion or accessory protein such as AdeA, AcrA, or
MexA, which is located in the periplasmic space; and an inner
membrane protein or transporter such as AdeB, AcrB, or MexB,
which is located in the bacterial inner membrane.2,3 Each of the
three components of tripartite eﬄux pumps assembles as a
homotrimer.4−6
The molecular structure of the inner membrane protein is
composed of three regions: (i) periplasmic regions, including
porter and docking domains (PN1, PN2, and DN) in its N-
terminal and also porter and docking domains (PC1, PC2, and
DC) in the C-terminal; (ii) pore regions; and (iii) trans-
membrane (TM) regions4−6 (Figure 1). Four subdomains of
PN1, PN2, PC1, and PC2 pack to form two proximal and distal
substrate-binding pockets, which are separated by a switch
glycine-rich loop, a part of PC1 with a Phe residue at the tip,
namely, a G-loop or a Phe loop. The Phe loop controls the
access of substrates to the distal pocket by forming a boundary
between the proximal and distal binding pockets.7 Under the
Phe loop, there is a narrow channel that connects the proximal
and distal pockets to each other. The pockets are enriched in
aromatic, polar, and charged amino acid residues that form
favorable interactions with the transported substrates. The
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proximal and distal pockets show substrate preferences and can
associate with diﬀerent antibiotics including β-lactams.8−10
The monomers of the inner membrane protein can adopt
three diﬀerent states: access (loose), binding (tight), and
extrude (release) to provide essential dynamics for the
eﬄux.4,9,11 Structures with bound drugs revealed two discrete
multisite binding pockets separated by a switch loop, with the
distal pocket in the binding (tight) state and the proximal
pocket in the access (loose) state.8,9
Acinetobacter baumannii is a Gram-negative bacillus that
causes numerous healthcare-associated infections worldwide,
with a propensity for nosocomial transmission.12 Reports have
demonstrated the involvement of both intrinsic and acquired
resistance determinants, as well as eﬄux pumps, in conferring
multidrug resistance.13 Several eﬄux pumps were identiﬁed and
shown to be associated with multidrug eﬄux prior to the
sequencing of the A. baumannii genome;3−5 for example, eﬄux
pumps adeABC, abeM, adeDE, and adeXY have been identiﬁed
in A. baumannii through genetic analysis.4,7,8,14 The over-
expression of the adeABC pumps has been experimentally
associated with the multidrug resistance phenotype in clinical
isolates of A. baumannii.9−11 In contrast, other transporter
components such as adeIJK, adeFGH, and adeT were identiﬁed
initially through genome analysis12 and have only recently been
shown to play a role in either intrinsic (adeIJK) or inducible
drug resistance (adeFGH).15
Eﬄux pump system AdeABC was identiﬁed in a MDR A.
baumannii strain in 2001.1 In A. baumannii, AdeB is the
multidrug transporter protein, AdeA is the membrane fusion
protein, and AdeC is the OMP.1 The eﬄux transporter (AdeB),
as an inner membrane protein of tripartite eﬄux pumps like
AcrD,16 captures its substrates either from within the
phospholipid bilayer of the inner membrane or from the
cytoplasm and then transports them into the extracellular
medium via the OMP (AdeC). Periplasmic protein AdeA
mediates the cooperation between the AdeB and AdeC
components. Drug transport by AdeB is driven by the TM
electrochemical gradient of protons. As a member of the RND
family, AdeABC eﬄux pumps are proton antiporters and
exchange H+ ions for drugs.17,18 The overexpression of this
system plays a pivotal role in eﬄux-mediated resistance in
clinical isolates19,20 and reduces the antimicrobial eﬃcacy of a
broad spectrum of antimicrobials including aminoglycosides,
tetracyclines, erythromycin, chloramphenicol (CHL), trimetho-
prim, ﬂuoroquinolones, some β-lactams,1,21−23 and tigecy-
cline.24,25
Phenylalanyl arginyl β-naphthylamide (PAβN) (Figure 2),
one of the best-studied eﬄux pump inhibitors (EPIs), is a
widely used EPI that has been reported as a substrate for the
MexAB−OprM pumps26 and AcrAB-TolC that follows a
sigmoidal kinetics27 and is also shown to inhibit eﬄux of
antibiotics24,28 and biocides29,30 in A. baumannii. PAβN has
been studied in a wide range of Gram-negative bacteria,
including A. baumannii, Enterobacter aerogenes, Klebsiella
pneumoniae, Salmonella enterica, Pseudomonas aeruginosa, and
Campylobacter jejuni,26,31−34 and has shown to potentiate the
activity of diﬀerent antibiotics through its eﬀect on a wide range
of eﬄux pumps. Mechanistically, PAβN acts as a competitive
inhibitor and prevents eﬄux of the antibiotics by binding with
the substrate-binding pocket of the eﬄux pumps, which leads to
potentiation of their activities.35−39 Alternatively, because of a
close location of the binding site, EPI binding may also
generate steric hindrance, impairing antibiotic binding at its
aﬃnity site. PAβN has shown to inhibit AcrAB-TolC in K.
pneumoniae, Escherichia coli, Salmonella typhimurium, and E.
aerogenes31,33,39,40 and multiple homologous systems including
AdeFGH and AdeABC in A. baumannii41,42 and CmeABC in C.
jejuni and Campylobacter coli.43,44
Agents that inhibit the tripartite eﬄux pump systems can play
a key role in reviving antibiotics to which bacteria have become
Figure 1. Proposed model structure of the AdeB eﬄux pump transporter from Acinetobacter baumannii. It represents the structure that was obtained
after carrying out homology modeling, minimization, and equilibration. The full-space complete homotrimer structure of AdeB has been shown on
the right side of the picture, and each subunit has been represented by diﬀerent colors. The side view of the binding conformer has been shown on
the left side of the picture. In addition, two top views of the docking (D) and pore (P) domains have been represented in the middle of the picture.
The DC (C-terminal) and DN (N-terminal) subdomains of the docking section have been indicated by the top view in the top middle panel, and the
PN1, PN2, PC1, and PC2 subdomains of the pore section have been indicated in the bottom middle picture with a 2 times magniﬁcation over the
others. PAβN has been shown in the binding domain.
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resistant.18,45−50 Understanding how the transport process
operates within the tripartite systems requires information on
the organization and interaction of the subunits within a full
tripartite assembly. Reconstituting tripartite assemblies for
experimental structural elucidation has been a technical
challenge, and simply mixing the components together does
not yield the assembled complexes in suﬃcient yield or purity
to enable analysis.51 With the help of the available structural
data, computational tools can be used to generate reliable
models of these tripartite pumps and molecular dynamics
(MD) simulations can provide detailed atomic-level informa-
tion between EPIs and tripartite systems and help the
researchers to understand the molecular mechanism of EPIs.
This information is essential for designing new classes of EPIs
with a better target aﬃnity and desired EPI activity for clinical
development.
In this study, for the ﬁrst time, the interaction of PAβN with
the binding monomer of A. baumannii AdeB homotrimer has
been studied computationally. The data on the direct inhibition
of AdeABC by PAβN appear to be contradictory. A number of
studies have shown a clear eﬀect of deletions in the
components of the AdeABC pump, giving rise to a >4-fold
increase in susceptibility to antibiotics such as GEN,
ciproﬂoxacin (CIP), and tigeycline (e.g., Richmond’s work),52
but the studies have not been able to replicate this eﬀect using
PAβN (ref 41 and Sutton et al., unpublished) with only a very
limited reduction in gentamicin (GEN) susceptibility observed
in some cases. Conversely, PAβN does have a clear eﬀect on
the susceptibility to rifampicin and clarithromycin in A.
baumannii, but the minimum inhibitory concentration of
these antibiotics is apparently unaﬀected by knockout mutants
or transposon insertions in adeABC (Sutton et al., unpub-
lished).
Although molecular interaction of PAβN or other broad-
spectrum EPIs with AdeB has not been studied to date, Vargiu
and Nikaido7 studied AcrB from E. coli, which is a similar eﬄux
pump to AdeB by MD. A sequence alignment study reveals
considerable diﬀerences (overall sequence identity 50.36%)
between the positions of the critical amino residues (Figure S1
and Table S1) within the binding sites of the two pumps.
Therefore, the interaction of EPIs with the binding sites of
these transporters can vary, which in turn can aﬀect the ability
of these inhibitors to potentially block the pump. In addition to
AdeB, there are other eﬄux pumps that also contribute to the
MDR phenotype in A. baumannii; there is clear evidence that
AdeB, as part of the AdeABC tripartite pump, is one of the
most important systems. This is in terms of both the range of
antibiotic classes that are potential substrates (e.g., mediating
clinical resistance to all aminoglycosides]15 and the distribution
of the eﬄux pump in MDR clinical isolates; prevalence
approaches 100% in many clinically important lineages.53−55
AdeB is a clinically important representative of the RND family
of multidrug transporters in A. baumannii, and as such, the
molecular mechanism of interaction of this pump with PAβN
will provide useful new information to understand the substrate
speciﬁcity of EPIs and balance the seemingly contradictory
results seen for PAβN inhibition in A. baumannii. This
information could then be used to design improved compounds
that alone or in combination with antibiotics can block these
MDR exporters and potentially sensitize resistant pathogens.
Figure 2. Structure (top) and atomtype (bottom) of phenylalanine-
arginine β-naphthylamide (PAβN).
Figure 3. (a) Homotrimer of AdeB in complex with PAβN. Each monomer of the trimer has been shown in a diﬀerent color; the best binding site in
the binding monomer determined by Smina molecular docking somewhere close to the distal pocket that has been represented by a black circle. (b)
PAβN in the multibinding sites within the binding protomer of the AdeB transporter.
ACS Omega Article
DOI: 10.1021/acsomega.7b00131
ACS Omega 2017, 2, 3002−3016
3004
2. RESULTS AND DISCUSSION
2.1. Binding Site. According to the Smina molecular
docking results, the location for binding of PAβN to the protein
structure was identiﬁed in the multisite binding pocket within
the binding protomer of the transporter (Figure 3). The
docked complex of PAβN−AdeB was comparable to the
previous structures determined for ligand-bound AcrB by
Nakashima et al.8 Only one PAβN was bound to the binding
monomer of the homotrimer, and it was bound only to the
multibinding site. Also, other favorable docked poses showed
that PAβN could bind to the access monomer of the AdeB
homotrimer, which suggests that PAβN could be forced to pass
through the path, during the dynamic of the eﬄux process, by a
transient conformational change from the access form to the
binding form and PAβN would move to the gate of the distal
pocket in the binding state. There were strong hydrophobic
interactions between PAβN and Phe612 of AdeB that is located
at the tip of the hairpin-like loop and forms a partition between
the proximal and distal binding pockets at the top of the
channel between the two pockets.
PAβN was found to bind to the narrow channel under Phe
loop and partly in the distal binding site of AdeB after
molecular docking (Figure 3b). The energy of binding, which
corresponds to the aﬃnity of the ﬁrst pose (the best pose),
obtained by the molecular docking of PAβN to the AdeB
transporter showed that PAβN could associate to the multisite
binding pocket with favorable aﬃnity. Molecular modeling
studies provided insight into the possible reason why PAβN
could increase the susceptibility of certain antibiotics while has
little eﬀect against other antibiotics. To explore this further, we
selected four antibiotics GEN, CHL, CIP, and levoﬂoxacin
(LEV) that are known substrates of AdeB. PAβN has shown to
potentiate the activity of LEV in P. aeruginosa but has little
eﬀect on other three antibiotics. A blind molecular docking
study was carried out to compare the binding site of these four
antibiotics with that of PAβN. The best pose of GEN binds to
the proximal binding pocket of the access protomer with an
aﬃnity of −9.6 kcal/mol, whereas the best poses of CIP and
CHL bind to the extrude tunnel of the extrude protomer with
aﬃnities of −8.8 and −7.9 kcal/mol, respectively, whereas the
best poses of PAβN and LEV bind to the distal pocket of the
binding protomer with aﬃnities of −9.3 and −7.7 kcal/mol
respectively. This is consistent with the observation of
Takatsuka et al.,56 who showed that, by molecular docking in
AcrB, PAβN predominantly binds to the hydrophobic groove
(distal binding site), whereas CHL binds to the proximal
binding pocket and is pumped out. Their docking study also
showed that LEV seems to bind, at least predominantly, with its
Table 1. Interactions between AdeB’s Key Residues and PAβN after GOLD Molecular Dockinga
AdeB−PAβN atoms distance category type
PAβN:N3:H−GLU665:OE2 2.2 hydrogen bond; electrostatic salt bridge; attractive charge
THR668:OG1−PAβN:O1:H 2.7 hydrogen bond conventional hydrogen bond
PAβN:N:H−SER134:OG 2.6 hydrogen bond conventional hydrogen bond
PAβN:N:H−SER134:O 1.7 hydrogen bond conventional hydrogen bond
PAβN:N:H−SER134:OG 2.9 hydrogen bond conventional hydrogen bond
PAβN:N2:H−GLU665:OE2 2.0 hydrogen bond conventional hydrogen bond
PAβN:N5:H−GLN42:OE1 2.2 hydrogen bond conventional hydrogen bond
PAβN:N4:H−GLU665:OE1 2.8 hydrogen bond conventional hydrogen bond
PAβN:N4:H−GLU665:OE2 2.9 hydrogen bond conventional hydrogen bond
PAβN:C9:H−THR668:OG1 3.0 hydrogen bond carbon hydrogen bond
ILE853:CD1−PAβN 3.6 hydrophobic π−σ
PHE612−PAβN 3.8 hydrophobic π−π stacked
PHE612−PAβN 3.7 hydrophobic π−π stacked
PHE669−PAβN 4.2 hydrophobic π−π stacked
PAβN−MET570 5.0 hydrophobic π-alkyl
aThe distance cutoﬀ and neighbor distance criterion were set to 5 and 4 Å, respectively. Proton donor−acceptor distance was considered for the H-
bonds.
Figure 4. (a) PAβN located at the gate of the distal binding pocket in the intermolecular channel of the multibinding site between the Phe612 and
Ser134 loops. The residues in stick presentation show the area of the binding site. (b) Top view of the multibinding site including PAβN in the
binding protomer of the AdeB homotrimer transporter.
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hydrophobic group bound to the upper groove of the binding
site and with its hydrophilic group often exposed in the very
wide substrate tunnel, which is in good agreement with the
LEV orientation observed in the distal binding site of AdeB in
the current study, which has been shown in Figure S2. In
another study, Lomovskaya et al.26 experimentally showed that
although PAβN inhibits the LEV eﬄux by MexB in S. aureus
and increases the susceptibility to this antibiotic, it was
surprisingly much less eﬀective in inhibiting the eﬄux of
ethidium and carbenicillin. Also, GEN, which is not a substrate
of MexB, was not aﬀected by PAβN. The results of the current
study also suggest that GEN, CHL, and CIP interact less
favorably with the distal binding pocket and the addition of
PAβN does not aﬀect the ability of the pump to extrude these
antibiotics as there is probably no competition between them
and PAβN. Therefore, the presence of PAβN has no eﬀect on
the susceptibility to these antibiotics. In contrast, as LEV
prefers to bind to the distal binding site with a good aﬃnity, it
could compete with PAβN for the distal binding pocket.
Therefore, the presence of PAβN could decrease the amount of
eﬄux of LEV by occupying the distal binding site. This
potentially explains why PAβN could increase the susceptibility
of certain antibiotics like LEV57 and not others like GEN, CIP,
and CHL.
2.2. Critical Interactions. GOLD molecular docking of
PAβN to the binding site, located by Smina, also showed that
the aﬃnity of PAβN to the AdeB transporter (ΔG −42.9 kcal/
mol and score 35.36) is favorable. Phe-cluster residues,
including Phe136, Phe178, Phe569, Phe612, Phe623, and
Phe669, provided eﬀective π interactions between the ligand
and the transporter. These strong interactions resulted in a
higher score and favorable docking energy.
The interactions between PAβN and the key residues of the
multibinding site of the AdeB transporter can be seen in Table
1 and Figure 4. PAβN binds to the space under the Phe loop,
toward the Phe-cluster region that partly overlaps the distal
binding site. PAβN is sandwiched between the Phe612 and
Ser134 loops (Figure 4a). Additionally, the side chains
containing residues Gln42 in the PN1 subdomain and the
side chain containing residue Glu665 in the PC2 subdomain
surround the guanidinium moiety of PAβN, and Met570 and
Phe612 interact hydrophobically with the phenyl and naphthyl
rings of PAβN, respectively. Ser134, Glu665, Thr668, and
Gln42 form hydrogen bonds with PAβN (Table 1).
Detection of PAβN into the narrow channel (under the Phe
loop) in AdeB suggests that the path under the Phe loop is
wide enough for PAβN to pass through the transporter (Figure
4b).
2.3. Interaction Energies of the Phe Residues of the
Distal Binding Site with PAβN. The analysis of the
interaction energies between the residues of the binding site
and PAβN in the complex shows the importance of the Phe
residues in the interaction of PAβN with the transporter (Table
2). These results show a good series of interaction energies
between PAβN and the Phe residues. More negative values in
Table 2 represent the Phe residues that provided key
interactions with PAβN at that time of the simulation. The
tightest-interaction energy extracted from diﬀerent snapshots of
MD trajectories belongs to Phe612, during the 50 ns
simulation. Table S2 series represent all of the interaction
energies between the ligand and the key residues of the protein
over the course of the MD simulation in which Phe and non-
Phe residues are involved. However, the Phe residues form a
hydrophobic microenvironment surrounding the ligand and
make the area of the distal site suitable for strong hydrophobic
interactions with ligands like PAβN and thereby prevent their
eﬄux.
The high interaction energies between the Phe residues and
PAβN during the MD simulation trajectories suggest the
ordered switching of PAβN to diﬀerent Phe residues to pass
through the narrow channel and then the distal binding pocket,
going toward the tunnel. PAβN appeared to behave like a
climber as we observed switching of the interaction energies
between the ligand and the key Phe residues of binding site
during the course of the simulation. It used the Phe residues of
the Phe-cluster as hooks to go forward in the channel. It
appeared to climb and move upward in the distal binding
pocket along the intramolecular channel of the transporter. The
more favorable energies (Table 2) belonged to Phe612, located
in the front, and Phe669, located behind PAβN (Figure 5).
This indicates that the ligand had attraction to both sides
simultaneously, which aided the forward movement by creating
a hydrophobic trap.
To provide further information and to explore the role of the
identiﬁed residues in ligand binding, we have carried out an in
silico mutagenesis study. Blind molecular docking was
performed to compare the aﬃnity of PAβN to that of the
mutated targets over the native form. The PAβn aﬃnity of −9.6
kcal/mol to the native distal binding pocket of AdeB decreased
for single mutant targets of F612G, F669G, and S134G to −8.4,
−8.5, and 7.7 kcal/mol, respectively. The aﬃnity after double
mutation decreased to −8.0 kcal/mol for F612G−S134G, and
surprisingly no pose in the distal binding pocket was observed
Table 2. Interaction Energy between Diﬀerent Phe Residues of the Phe-Cluster and PAβN in the AdeB−PAβN Complex during
MD Simulationa
time (ns) 0 5 10 15 20 25 30 35 40 45 50
Phe residue and energy
(kJ/mol)
Phe136 Phe136 Phe136 Phe136 Phe136 Phe136 Phe136 Phe136 Phe136 Phe136 Phe136
−7.34 −5.13 −2.348 −0.78 −1.75 −1.19 −1.78 −1.78 −2.83 −3.2 −2.40
Phe612 Phe612 Phe612 Phe573 Phe612 Phe573 Phe573 Phe573 Phe573 Phe573 Phe573
−31.67 −18.89 −26.52 −0.86 −26.06 −0.32 −0.37 −0.37 −0.43 −0.38 −0.56
Phe 623 Phe669 Phe669 Phe612 Phe669 Phe612 Phe612 Phe612 Phe612 Phe612 Phe612
−2.57 −21.34 −21.48 −31.14 −19.19 −21.73 −27.86 −27.86 −34.62 −32.63 −27.75
Phe669 Phe669 Phe669 Phe669 Phe669 Phe669 Phe669 Phe669
−17.52 −19.97 −17.18 −18.72 −18.72 −21.45 −16.95 −13.56
Phe 672
−0.98
aThe most favorable energy in each snapshot has been represented in bold font format that belongs to Phe12.
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Figure 5. (a) Three-dimensional (3D) structure of PAβN in the binding monomer of A. baumannii AdeB. The average structure was calculated from
the MD trajectories with surface format; the blue color represents low hydrophobicity (the side of the proximal binding site), and the brown areas
represent the highly hydrophobic (the side of the distal binding pocket) region. (b) Three-dimensional structures of PAβN involved in the
interaction with the binding monomer of AdeB. H-bonds are shown by the dotted green line and hydrophobic interactions by dotted pink lines. (c)
Two-dimensional structure of PAβN in AdeB’s binding site; the average structure of the complex (the ﬁgures were generated using the Accelrys
discovery studio).
ACS Omega Article
DOI: 10.1021/acsomega.7b00131
ACS Omega 2017, 2, 3002−3016
3007
for F612G−F669G. This in silico mutagenesis study further
supports the importance of the identiﬁed residues in ligand
binding. The distances between PAβN and each of the Phe
residues that are close to the binding site were monitored
during the 50 ns MD simulation of the complex (Figure 6).
The distance between PAβN and the residue at the tip of the
Phe loop in AdeB (Phe612) gradually decreased during the
course of the simulation. It can be seen from Figure 6 that the
trend of distances between Phe residues and PAβN during the
course of MD simulation does not vary considerably, implying
that the ligand faces considerable hindrance when passing
through the Phe residues and the binding site, thus making its
extrusion diﬃcult.
Figure 7 shows the orientation of PAβN at the beginning,
middle, and at the end of the MD simulations in the multisite
pockets of the AdeB transporter. The Ser loop of the PN1
domain is on the other side of the narrow channel, under the
Phe loop of PC1. The distance between Phe612 and Ser134
plays a critical role in modulating the size of channel’s width,
consequentially switching the ligand-accessible conformers of
the binding protomer. This improved access allowed PAβN to
bind to the binding site.
Figure S3a shows the changes in the width of the channel
during the 50 ns MD simulation by monitoring the distance
between Phe612 and Ser134. The channel width remains
between 10 and 14 Å, which is wide enough for PAβN to pass
through, as a small-molecular-mass ligand, during the course of
the simulation.
2.4. Hydrogen Bond Analysis. The analysis of hydrogen
bonds formed between the ligand and protein in the 50 ns MD
trajectory showed just a few nonpermanent H-bond inter-
actions (Table 3). Because the occupancy of these hydrogen
bonds is relatively low (Table 3) during the simulation, the
hydrogen-bonding interactions are unlikely to play dominant
roles in the association of PAβN with the transporter. On the
other hand, the hydrophobic interactions involving the Phe
residues and PAβN remained strong during the course of MD
simulation and most likely played a more signiﬁcant role.
The ﬂuctuation of the distance between a residue (Gln292)
and the ligand during the MD simulation can be seen in
FigureS2b. Although Gln292 has a potential to form hydrogen
bond with PAβN, the distance between them in the ﬁrst 30 ns
was often more than 3.5 Å. This indicates that the hydrogen
bond that may form is relatively short-lived and is unlikely to
play an important role in the association between PAβN and
the transporter.
2.5. Hydrophobic Microenvironment. The microenvir-
onment of the binding site, surrounded by the nonpolar Phe
residues and polar residues such as GLu89, Ser134, Ser670,
Gln42, and Gln292, is shown in Figure 5c. Nonpolar residues
provide a hydrophobic trap around PAβN in AdeB. Particularly,
Phe residues that are in close contact with the ligand are
important participants of the hydrophobic microenvironment.
The hydrophobic microenvironment can also potentially help
in strengthening the electrostatic interactions58,59 between the
ligand and the binding site residues (Figure 5a,b). This
Figure 6. Distances between PAβN (atom N2) and residues of Phe-cluster (atom CG in the benzene ring of each Phe residue) in the multibinding
site of the transporter.
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observation is the key to understanding the inhibition of the
AdeB transporter by PAβN as this strong interaction traps the
ligand in the binding pocket and consequently prevents the
conformational switch.
The number and location of the Phe residues around the
ligand were pivotal in creating a hydrophobic microenviron-
ment, and the residues of the binding site of AdeB mostly
interacted with PAβN through the formation of hydrophobic
interactions, as seen in Figure 5b. Moreover, although some H-
bonds can be observed, they do not appear to play any
signiﬁcant role due to their relatively short life time during the
course of the simulation. The interactions between the key
residues of the binding site of the AdeB transporter and PAβN
after the 50 ns simulation can be seen in Table 4. The
phenylalanine and β-naphthylamide groups of PAβN are
involved in π interactions with Phe residues in the more
hydrophobic part of the binding pocket, and the arginine
residue of PAβN is involved in forming H-bonds with some
residues such as Ser134, Gln42, Gln292, and Thr668 of the less
hydrophobic part of the binding site.
2.6. Binding Free Energy. A total of 20 snapshots were
collected from the last 200 ps of the MD simulation of the
complex, and the binding free energy was calculated using the
molecular mechanics, Poisson−Boltzmann surface area/molec-
ular mechanics, generalized Born surface area (MM-PBSA/
MM-GBSA) method.
The ΔGPB value of −24.29 kcal/mol, obtained by MM-
PBSA/MM-GBSA calculations, showed that the PAβN−AdeB
complex is favorable (Table 5). In the binding free energy
calculation, because normal mode analysis for calculating the
entropy contribution is a time-consuming exercise even with
good supercomputers, the value of 20 kcal/mol was considered
for the contribution of the −TΔS term in ligand binding, which
has been used in the literature for similar ligands.60 This
provides a standard binding free energy (ΔGbind) of −4.54 kcal/
mol. The ﬁnal estimated binding free energy (ΔGGB) value of
−34.06 kcal/mol further conﬁrms that the complex between
the ligand and the transporter is favorable.
The dissociation constant (Kd) for PAβN was obtained using
the calculated total binding free energy using formula ΔG = RT
ln Kd. Because the total binding free energy is directly
proportional to the Kd value and inversely proportional to
the binding aﬃnity, the calculated value of 4.9 × 10−6 M for Kd
suggests that PAβN binds to the transporter with a high aﬃnity
and acts as an inhibitor for the AdeB transporter.
2.7. Movement of PAβN across the Enter and Exit
Tunnels. The analysis of the PAβN−transporter complex after
the MD simulation using the MOLE 2.13.9.6 toolkit showed
the possible entrance tunnels from the vestibule, from the lower
external depression, and from the central cavity and also one
exit port (Figure 8a). The exit port has access to the central
cavity, the space between the three monomers of the
transporter in the middle of the homotrimer structure, and
the entrance ports have access to the periplasm or cytoplasm.
The general entrance and exit points for the AdeB eﬄux pump
transporter share structural similarity with the tunnels identiﬁed
in P. aeruginosa AcrB and MexB by Nakashima et al.8,61
The key residues that are located in the gates of the tunnel
are Leu666, Ser462, and Ser670 (Figure 8b). These amino acids
play an important role in the movement of PAβN across the
channel. Leu666 is located at the junction of channels 1 and 2,
whereas Ser462 is halfway along channel 1 in the transporter
and Ser670 of AdeB is located at the entrance of channel 2. The
channels are between 1.35 and 3.85 Å wide, and this should
allow PAβN to enter into the channels and move toward the
exit port.
AdeB has two spacious multisite drug-binding pockets that
line the drug translocation channel. PAβN, which is taken up
Figure 7. Structural snapshots at 0, 25, and 50 ns of the MD
simulation showing the diﬀerent orientations of PAβN within
multibinding sites of the AdeB transporter and conformational
changes of the Phe loop and Ser loop in the multibinding sites.
Table 3. Hydrogen Bonds Formed between PAβN and the Transporter during the 50 ns MD Simulationa
acceptor (res/atom) donor (res/atom) occupancy (%) distance (Å) angle (deg)
Gln292/NE2 PAβN/N 42.46 3.195 (0.19) 125.85 (22.09)
Glu665/OE2 PAβN/N4 19.38 2.940 (0.18) 68.35 (49.84)
PAβN/O1 Thr668/OG1 22.33 2.938 (0.22) 31.79 (20.40)
aDistance cutoﬀ was set at 3.5 Å. Standard deviations are shown in parentheses.
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from the three possible entrances, could be transported by a
peristaltic mechanism62 through both pockets and can be
potentially extruded from the top exit. The average structure
obtained after the 50 ns MD simulation for the complex
(Figure S4a) suggest that PAβN can enter into the binding
monomer in the AdeB transporter with relative ease. Therefore,
PAβN might act as a substrate for the AdeB transporter. In
addition, according to the radius proﬁle of the tunnels for
entering and exporting of PAβN detected in the transporter
(Figure S4b,c), the tunnels form internal pores that are wide
enough to allow PAβN to pass through. Also Figure S5 depicts
the view of the entrance and exit gates of PAβN in the AdeB
transporter from the outside, which suggests that it may be
possible to extrude PAβN from the transporter. However,
because of the strong hydrophobic interaction with the Phe
residues located within the binding pocket, it is likely that
PAβN would remain trapped within the Phe-cluster and could
not be extruded by the transporter.
2.8. Fluctuations and Flexibility of Binding Monomer
Residues. According to the literature on the binding
monomer, the Phe loop swings toward the ligand-binding site
and, as a result, prevents ligands from binding to the proximal
pocket in the binding monomer of AcrB and glycine residues in
the Phe loop have a critical role in loop translocation.8 In this
study, the ﬂuctuation of the residues in the ligand-free
transporter and AdeB transporter in complex with PAβN
during the course of MD simulation showed a considerably
diﬀerent root-mean-square ﬂuctuation for Phe612 of AdeB in
complex with PAβN in comparison to that in the ligand-free
form of AdeB (Figure 9), which conﬁrms the swing motion of
the Phe loop. Additionally, an essential dynamics analysis has
been performed (Figure S6), which further validates the swing
motion of the Phe loop.
Binding monomer’s residues in the complex exhibited a
slightly more ﬂexibility just for 50% of residues than that of the
ligand-free form of the transporter in the structural alignment
analysis (Figure 9). However, the key residues involved in the
interaction with PAβN (e.g., Phe612, Phe136, Phe623, Phe669,
and Phe672) showed notably less ﬂexibility compared to that of
the other residues of the binding monomer. This suggests that
the presence of PAβN may have provided additional stability to
the binding monomer. This can potentially prevent the
switching of binding monomers to diﬀerent conformations
that are required to extrude a ligand by the transporter. This
additional stability can be explained by the architecture of the
binding site and its building blocks, particularly Phe building
blocks. The presence of the Phe residues in the distal binding
site creates a hydrophobic pocket. The energy calculation
provides evidence that the Phe residues of the binding
monomer in the form of Phe-clusters favorably interact with
PAβN and trap the ligand in the distal pocket. This ultimately
leads to the inhibition of the peristaltic mechanism and
prevents the exporter from extruding any other substrates,
leading to the inhibition of the tripartite pump. This
observation is similar to that observed by Vargiu and Nikaido7
for the PAβN interaction with the AcrB multibinding site. The
movement of PAβN in the AcrB multibinding site caused it to
straddle the G-loop (Phe617 loop) structure, which contributed
Table 4. Diﬀerent Kinds of Interactions between AdeB’s Key Residues and PAβN after the 50 ns MD Simulationa
AdeB−PAβN atoms distance category types
GLN292/HE21 PAβN/N 2.38872 hydrogen bond conventional hydrogen bond
PAβN/N/H SER134/O 2.06319 hydrogen bond conventional hydrogen bond
PAβN/N2/H PHE669/O 1.81724 hydrogen bond conventional hydrogen bond
PAβN/N4/H GLN42/OE1 2.27647 hydrogen bond conventional hydrogen bond
PHE612/HN PAβN 2.32546 hydrogen bond π-donor hydrogen bond
PHE612 PAβN 5.56607 hydrophobic π−π T-shaped
PAβN VAL621 5.4717 hydrophobic π-alkyl
PAβN VAL619 4.63171 hydrophobic π-alkyl
PAβN VAL621 4.46385 hydrophobic π-alkyl
aThe distance cutoﬀ and neighbor distance criterion were set to 5 and 4 Å, respectively. Proton donor−acceptor distances were considered for the
H-bonds.
Table 5. Average Energy Contributions To Form the AdeB−
PAβN Complex (kcal/mol) and Inhibition Constants (Ki/m
in Molar) with Standard Errors of the Mean (in
Parentheses)
complexc A. baumannii AdeB−PAβN
ΔEele −30.36 (3.95)
ΔEvdw −55.42 (1.99)
ΔEint 0.00
ΔEGAS(MM) −85.78 (4.43)
ΔEPBsur −8.09 (0.66)
ΔEPBcal 69.58 (4.34)
ΔEPBsol 61.49 (4.55)
ΔEPBele 39.21 (4.38)
ΔGPB −24.29 (3.94)
ΔEGBsur −8.09 (0.66)
ΔEGBcal 59.81 (3.23)
ΔEGBsol 51.73 (3.44)
ΔEGBele 29.45 (3.06)
ΔGGB −34.06 (3.40)
−TΔSa 20
ΔGbind −4.54
Kd
b 4.9 × 10−6
aEstimated value based on the published results for similar-sized
ligands.60 bKd is calculated through formula ΔG = RT ln Kd using the
values of binding energies resulted from analyzing simulations. cΔEELE
= electrostatic energy as calculated by the MM force ﬁeld; ΔEvdw = van
der Waals contribution from MM; ΔEINT = internal energy arising
from the bond, angle, and dihedral terms in the MM force ﬁeld (this
term always amounts to 0 in the single trajectory approach);
ΔEGAS(MM) = total gas-phase energy (sum of ELE, vdw, and INT);
ΔEPBSUR/ΔEGBSUR = nonpolar contribution to the solvation free
energy calculated by an empirical model; ΔEPBCAL/ΔEGBCAL = the
electrostatic contribution to the solvation free energy calculated by PB
or GB, respectively; ΔEPBSOL/ΔEGBSOL = sum of nonpolar and polar
contributions to solvation; ΔEPBELE/ΔEGBELE = sum of the electro-
static solvation free energy and MM electrostatic energy; ΔGPB/ΔGGB
= ﬁnal estimated binding free energy calculated from the terms above
(kcal/mol).
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to its ability to form interactions with the Phe residues.
Recently, Kinana and co-workers27 suggested that PAβN
inhibits the eﬄux of other drugs by binding to the hydrophobic
trap in the distal binding pocket of AcrB and interfering with
the binding of other drug substrates to the upper part of the
binding pocket. Our results for the AdeB transporter, in good
agreement with the recent study, showed that PAβN does not
considerably move inside AdeB and has a consistently strong
interaction with Phe612 and other Phe residues of the distal
binding pocket. The interaction of PAβN with the hydrophobic
trap reduces the ﬂexibility of the transporter, and this partly
explains some of the inhibition mechanisms of PAβN. The
study provides new information about the dual nature, a
substrate and an inhibitor, of PAβN in its interaction with AdeB
and partially explains the contradictory nature of the
experimental data available in the literature.
It is urgent to develop speciﬁc inhibitors of eﬄux pumps to
suppress the activities of these pumps and restore the sensitivity
of bacteria, such as A. baumannii, to commonly used antibiotics
to reverse antimicrobial resistance. Understanding the way in
which the AdeB transporters identify and transport agents will
help researchers to develop new strategies to tackle eﬄux-
mediated resistance63 and may provide inhibitors that will
improve the eﬃcacy of current antibiotics that are used to treat
MDR infections in the clinic.61 Development of molecular
models of these tripartite pumps and their interaction with EPIs
also pave the way to study a large number of potential leadlike
molecules to develop potential inhibitors of these pumps.
3. CONCLUSIONS
Information obtained from this study provides detailed insight
into the interaction of PAβN with the AdeB transporter in A.
baumannii. The amino acid sequences in the binding site of the
pump dictate the way in which PAβN interacts and either
inhibits the transporter by interacting with the hydrophobic
microenvironment with diverse strengths in the binding site of
the complex or gets eﬄuxed through the tunnel. It appeared
from this study that the location and number of Phe residues, in
the binding site, played a crucial role in stabilizing the PAβN−
AdeB complex and kept the binding monomer in the binding
stage. This could prevent the conformational switch of the
binding monomer to access stage, which is essential to continue
the peristaltic mechanism of the tripartite pump. We hope that
the passage of PAβN through the transporter, the structure of
the hydrophobic trap described in this study, and identiﬁcation
of the key residues of AdeB that interact with PAβN during the
Figure 8. (a) General pattern for the entrance and exit ports in the binding monomer of the AdeB transporter (PAβN is in yellow color). (b)
Zoomed-in view of the red circled area in (a) that shows the diﬀerent entrance and exit tunnels in the AdeB transporter. The key residues located in
the gates of tunnels and borders of the multisite binding pockets have been labeled. The green lines show the path of the travel of substrates through
the pump.
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simulation could contribute to the design of new eﬀective and
selective EPIs that may play key roles in reversing antimicrobial
resistance.
4. COMPUTATIONAL METHODS
We explored the interaction of PAβN with the AdeB eﬄux
pump transporter of A. baumannii using diﬀerent computa-
tional methods, including MD simulation, MM-PBSA/MM-
GBSA calculation, and molecular docking. Homology modeling
was applied for the generation of the structural model of the
homotrimer transporter in a PDB format.
4.1. Homology Modeling. The Swiss-Model web-
server64−68 was used for the homology modeling of the AdeB
structural model using the FASTA formatted target sequence
with UniProt entry number of B7I7F7_ACIB5, represented at
the end of the Supporting Information. The crystal structure of
AcrB from E. coli (PDB ID 1IWG) was selected as a template
with a sequence identity of 50.36% in the amino acid sequence
of the target. A comparison between the critical residues of the
developed AdeB model and the template AcrB model is shown
in Table S1.
The trimer of the AdeB protein was obtained as the ﬁnal
model from homology modeling in a 3D PDB structure format.
The template that we used for the homology modeling was a
monomer structure; therefore, the generated model was also a
monomer structure and the assembly procedure was performed
using the Accelrys discovery studio.69 The generated model was
without any gap, and all of the segments were solved. Accelrys
discovery studio 4.5 was used to add probable missing side
chains in the generated model. However, to eliminate the
possibilities of steric clashes and suboptimal geometries, the
structure was successfully minimized by the AMBER package
program70,71 before carrying out the MD simulations. The
minimization was performed in vacuum through 1500 cycles,
wherein 500 cycles of steepest descent were followed by 1000
cycles of conjugate gradient minimization. Figure S7 shows the
validation of the structural model for the AdeB model,
including the residue-wise proﬁle, using ProSA analysis (protein
structure analysis).72,73 The Z-score of the model was within
the range of scores calculated for proteins of similar size with
experimentally determined structures, indicating good overall
quality of the built model. The local similarity of AdeB
monomers to the template target is shown in Figure S8.
4.2. Molecular Docking. Molecular docking protocols are
methods that predict the preferred orientation of a bound
ligand to a target that forms a stable complex. Knowledge of the
preferred orientation in turn may be used to predict the
strength of association between two molecules. For example,
molecular docking has been performed to generate several
distinct binding orientations and binding aﬃnity for each
binding mode. Subsequently, the lowest binding free energy has
been considered as the most favorable binding mode for the
system.
AutoDock Smina,74 which uses the AutoDock Vina scoring
function by default, was used for the blind molecular docking of
PAβN to the AdeB structure for ﬁnding the best binding site in
the homotrimer by exploring all probable binding cavities of the
proteins. Smina was performed with default settings, which
samples nine ligand conformations using the Vina docking
routine of stochastic sampling. Then, GOLD molecular
docking75,76 was applied for the docking of PAβN to the
Smina-located best binding site of the homotrimer for
performing ﬂexible molecular docking. On the basis of the
ﬁtness function scores and ligand-binding positions, the best-
docked poses for the PAβN were selected. The lower ﬁtness
function score of the poses, generated using the GOLD
program that has the highest GOLD ﬁtness energy, reveals the
best-docked pose.
The GOLD molecular docking procedure was performed by
applying the GOLD protocol76 in Accelrys discovery studio
software. The genetic algorithm (GA) was used in GOLD
ligand docking software to examine thoroughly the ligand
conformational ﬂexibility along with the partial ﬂexibility of the
protein.77 The maximum number of runs for the ligand was set
to 20, and in each run, a population size of 100 with 100 000
operations was employed. The number of islands was 5, and the
Figure 9. Atomic positional ﬂuctuations (Å) of Cα atoms in the ligand-bound transporter (blue line) compared to those in the ligand-free protein
(red line) in A. baumannii AdeB. The key residues, Phe612, Phe136, Phe623, Phe669, and Phe672, show notably less ﬂexibility compared to that of
the other residues.
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niche size of 2 was considered. The default cutoﬀ value for
hydrogen bonds was set to 2.5 Å (dH-X), and for the van der
Waals distance, it was 4.0 Å. The GA docking was terminated
when the top solutions attained the root-mean-square deviation
(RMSD) values within 1.5 Å.78
4.3. MD Simulation. In this study, three MD simulation
runs have been performed. The systems consisted of free
PAβN, ligand-free protein of the A. baumannii AdeB
homotrimer transporter, and a complex of PAβN−transporter
that was obtained by GOLD molecular docking.
After the molecular docking, three 50 ns independent MD
simulations were performed for the complex, ligand-free
protein, and free ligand, which were followed by MM-PBSA/
MM-GBSA calculations. All of the MD simulations were carried
out using the AMBER 12.0 package. Each system was solvated
using an octahedral box of TIP3P water molecules with a size of
174.81 × 153.69 × 229.20. Periodic boundary conditions and
the particle-mesh Ewald method were employed in the
simulations.79 Particle-mesh Ewald method enabled us to
calculate the “inﬁnite” electrostatics without truncating the
parameters. During each simulation, all bonds in which the
hydrogen atom was present were considered ﬁxed and all other
bonds were constrained to their equilibrium values by applying
the SHAKE algorithm.80 The force ﬁeld parameters for the
ligand were generated using the ANTECHAMBER module of
the AMBER program.
A cutoﬀ radius of noncovalent interactions was set to 12 Å
for the protein and complex, whereas for the free ligand
simulations, the cutoﬀ radius was set to 10 Å. Each
minimization and equilibration phase was performed in two
stages. In the ﬁrst stage, ions and all water molecules were
minimized for 500 cycles of steepest descent followed by 500
cycles of conjugate gradient minimization. Afterward, the whole
system was minimized for a total of 2500 cycles without a
restraint, wherein 1000 cycles of steepest descent were followed
by 1500 cycles of conjugate gradient minimization. In the
second stage, the systems were equilibrated for 500 ps, whereas
the temperature was raised from 0 to 300 K. Then,
equilibration was performed without a restraint for 100 ps,
whereas the temperature was kept at 300 K. Sampling of
reasonable conﬁgurations was conducted by running a 50 ns
simulation with a 2 fs time step at 300 K and 1 atm pressure. A
constant temperature was maintained by applying the Langevin
algorithm, whereas the pressure was controlled by the isotropic
position scaling protocol used in AMBER.81 Time dependence
of RMSD (Å) for the backbone atoms relative to the starting
structure during 50 ns MD simulations of both ligand-free and
ligand-bound AdeB is shown in Figure S9. RMSD curves show
that both simulations have reached equilibrium after ∼30 ns,
indicated by the relatively stable RMSD values from 30 ns to
the end of the simulations.
4.4. MM-PBSA/MM-GBSA Calculations. Twenty snap-
shots were collected from the last 200 ps of simulations of the
protein−ligand complex for post-processing analysis. The gas-
phase interaction energy between the protein and the ligand,
ΔEMM, is the sum of electrostatic (ΔEELE), internal (ΔEINT),
and van der Waals (ΔEvdw) interaction energies. The solvation
free energy, ΔGsol, is the sum of polar (ΔGPB) and nonpolar
(ΔGSA) parts. The ΔGPB term was calculated by solving the
ﬁnite-diﬀerence Poisson−Boltzmann equation using the
internal PBSA program.71 The SCALE value was set to 5.
The Parse radii were employed for all atoms.82 The solvent
probe radius was set at 1.4 Å (with the radii in the prmtop
ﬁles). MM-PBSA running was performed with the PBSA
module (PROC = 2). The value of the exterior dielectric
constant was set at 80, and the solute dielectric constant was set
at 1.83 The nonpolar contribution was determined on the basis
of the solvent-accessible surface area (SASA) using the LCPO
method,84 ΔGSA = 0.04356 × ΔSASA, and CAVITY-OFFSET
set at −1.008. Solute entropic contributions (−TΔS) were
assumed to be +20 kcal/mol for the ligand in the complex.60
Δ = Δ − ΔG G T Sbind PB/GB
Δ = Δ + ΔG E EPB/GB GAS(MM) PB/GBsol
Δ = Δ + Δ + ΔE E E EGAS(MM) internal electrostatic vdw
Δ = Δ + ΔE E EPB/GBsol PB/GBsur PB/GBcal
In the MM-GBSA calculations, like the MM-PBSA calculations,
the gas-phase interaction energy (ΔEGAS(MM)) and the nonpolar
and polar (ΔEPB/GBsol) parts of the solvation energy were
calculated. The electrostatic solvation energy (ΔGGB) was
calculated using GB models.85 A value of 80 was used for the
exterior dielectric constant, and a value of 1 was used for the
solute dielectric constant. The binding free energies were
calculated using both the MM-PBSA and MM-GBSA methods.
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Kolossvaŕy, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Wolf, R. M.; Liu,
J.; Wu, X.; Brozell, S. R.; Steinbrecher, T.; Gohlke, H.; Cai, Q.; Wang,
X.; Ye, J.; Hsieh, M.-J.; Cui, G.; Roe, D. R.; Mathews, D. H.; Seetin, M.
G.; Salomon-Ferrer, R.; Sagui, C.; Babin, V.; Luchko, T.; Gusarov, S.;
Kovalenko, A.; Kollman, P. A. AMBER 12; University of California:
San Francisco, 2012.
(72) Sippl, M. J. Recognition of errors in three-dimensional
structures of proteins. Proteins 1993, 17, 355−362.
(73) Wiederstein, M.; Sippl, M. J. ProSA-web: interactive web service
for the recognition of errors in three-dimensional structures of
proteins. Nucleic Acids Res. 2007, 35, W407−W410.
(74) Koes, D. R.; Baumgartner, M. P.; Camacho, C. J. Lessons
learned in empirical scoring with smina from the CSAR 2011
benchmarking exercise. J. Chem. Inf. Model. 2013, 53, 1893−1904.
(75) Jones, G.; Willett, P.; Glen, R. C. Molecular recognition of
receptor sites using a genetic algorithm with a description of
desolvation. J. Mol. Biol. 1995, 245, 43−53.
(76) Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R.
Development and validation of a genetic algorithm for flexible docking.
J. Mol. Biol. 1997, 267, 727−748.
(77) Nissink, J. W.; Murray, C.; Hartshorn, M.; Verdonk, M. L.; Cole,
J. C.; Taylor, R. A new test set for validating predictions of protein-
ligand interaction. Proteins 2002, 49, 457−471.
(78) Jamshidi, S.; Rafii-Tabar, H.; Jalili, S. Investigation into
mechanism of orotidine 5′-monophosphate decarboxylase enzyme by
MM-PBSA/MM-GBSA and molecular docking. Mol. Simul. 2014, 40,
469−476.
ACS Omega Article
DOI: 10.1021/acsomega.7b00131
ACS Omega 2017, 2, 3002−3016
3015
(79) Darden, T.; York, D.; Pedersen, L. Particle Mesh Ewald - an
N.Log(N) Method for Ewald Sums in Large Systems. J. Chem. Phys.
1993, 98, 10089.
(80) Ryckaert, J. P.; Ciccotti, G.; Berendsen, H. J. C. Numerical-
Integration of Cartesian Equations of Motion of a System with
Constraints - Molecular-Dynamics of N-Alkanes. J. Comput. Phys.
1977, 23, 327.
(81) Case, D. A.; Cheatham, T. E.; Darden, T.; Gohlke, H.; Luo, R.;
Merz, K. M.; Onufriev, A.; Simmerling, C.; Wang, B.; Woods, R. J. The
Amber biomolecular simulation programs. J. Comput. Chem. 2005, 26,
1668−1688.
(82) Sitkoff, D.; Sharp, K. A.; Honig, B. Accurate Calculation of
Hydration Free-Energies Using Macroscopic Solvent Models. J. Phys.
Chem. 1994, 98, 1978−1988.
(83) Wang, W.; Kollman, P. A. Free energy calculations on dimer
stability of the HIV protease using molecular dynamics and a
continuum solvent model. J. Mol. Biol. 2000, 303, 567.
(84) Weiser, J.; Shenkin, P. S.; Still, W. C. Approximate atomic
surfaces from linear combinations of pairwise overlaps (LCPO). J.
Comput. Chem. 1999, 20, 217−230.
(85) Tsui, V.; Case, D. A. Theory and applications of the generalized
Born solvation model in macromolecular simulations. Biopolymers
2000, 56, 275−291.
ACS Omega Article
DOI: 10.1021/acsomega.7b00131
ACS Omega 2017, 2, 3002−3016
3016
